603669 灵康药业
已收盘 05-20 15:00:00
资讯
新帖
简况
灵康药业（603669）披露“灵康转债”预计满足转股价格修正条件提示性公告，5月19日股价上涨0.69%
证券之星 · 05-19 18:18
灵康药业（603669）披露“灵康转债”预计满足转股价格修正条件提示性公告，5月19日股价上涨0.69%
每周股票复盘：灵康药业（603669）一季报主营收入同比上升72.65%
证券之星 · 05-02
每周股票复盘：灵康药业（603669）一季报主营收入同比上升72.65%
灵康药业（603669）2026年一季报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 04-30
灵康药业（603669）2026年一季报简析：营收净利润同比双双增长，盈利能力上升
图解灵康药业年报：第四季度单季净利润同比下降89.26%
证券之星 · 04-29
图解灵康药业年报：第四季度单季净利润同比下降89.26%
每周股票复盘：灵康药业（603669）回购股份注销不调转股价
证券之星 · 04-26
每周股票复盘：灵康药业（603669）回购股份注销不调转股价
灵康药业（603669）披露关于延期披露2025年年度报告及2026年第一季度报告的公告，4月24日股价上涨0.23%
证券之星 · 04-24
灵康药业（603669）披露关于延期披露2025年年度报告及2026年第一季度报告的公告，4月24日股价上涨0.23%
灵康药业（603669）披露关于变更持续督导保荐代表人的公告，4月7日股价上涨1.42%
证券之星 · 04-07
灵康药业（603669）披露关于变更持续督导保荐代表人的公告，4月7日股价上涨1.42%
每周股票复盘：灵康药业（603669）灵康转债一季度转股金额为0元
证券之星 · 04-05
每周股票复盘：灵康药业（603669）灵康转债一季度转股金额为0元
每周股票复盘：灵康药业（603669）回应业绩预告问询
证券之星 · 03-29
每周股票复盘：灵康药业（603669）回应业绩预告问询
股市必读：新发布《中审亚太会计师事务所（特殊普通合伙）关于对灵康药业集团股份有限公司业绩预告有关事项的问询函的回复》
证券之星 · 03-26
股市必读：新发布《中审亚太会计师事务所（特殊普通合伙）关于对灵康药业集团股份有限公司业绩预告有关事项的问询函的回复》
生物医药板块午后再度拉升 灵康药业触及涨停
每日经济新闻 · 03-24
生物医药板块午后再度拉升 灵康药业触及涨停
股市必读：灵康药业（603669）3月23日收盘跌6.68%，主力净流出101.48万元
证券之星 · 03-24
股市必读：灵康药业（603669）3月23日收盘跌6.68%，主力净流出101.48万元
每周股票复盘：灵康药业（603669）变更签字会计师及注销891万回购股份
证券之星 · 03-08
每周股票复盘：灵康药业（603669）变更签字会计师及注销891万回购股份
灵康药业（603669）披露关于变更回购股份用途并注销暨减少注册资本的议案，3月5日股价上涨2.09%
证券之星 · 03-05
灵康药业（603669）披露关于变更回购股份用途并注销暨减少注册资本的议案，3月5日股价上涨2.09%
灵康药业（603669）披露变更签字注册会计师公告，3月2日股价下跌3.43%
证券之星 · 03-02
灵康药业（603669）披露变更签字注册会计师公告，3月2日股价下跌3.43%
灵康药业（603669）披露回购股份用途变更公告，2月27日股价上涨1.3%
证券之星 · 02-27
灵康药业（603669）披露回购股份用途变更公告，2月27日股价上涨1.3%
每周股票复盘：灵康药业（603669）2025年净利预亏1.27亿元
证券之星 · 02-08
每周股票复盘：灵康药业（603669）2025年净利预亏1.27亿元
灵康药业（603669）披露2025年度业绩预亏公告，2月6日股价上涨1.3%
证券之星 · 02-06
灵康药业（603669）披露2025年度业绩预亏公告，2月6日股价上涨1.3%
每周股票复盘：灵康药业（603669）拟注销近892万股并减少注册资本
证券之星 · 02-01
每周股票复盘：灵康药业（603669）拟注销近892万股并减少注册资本
灵康药业（603669）披露2025年年度业绩预告，1月23日股价上涨1.24%
证券之星 · 01-23
灵康药业（603669）披露2025年年度业绩预告，1月23日股价上涨1.24%
加载更多
公司概况
公司名称：
灵康药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2015-05-28
主营业务：
灵康药业集团股份有限公司的主营业务是化药处方药的研发、生产和销售。公司的主要产品是抗感染类产品、肠外营养类产品、消化系统类产品、心脑血管类产品、其他药品类产品、医药流通、医院销售、配送。公司先后获得“中国创新力医药企业”、“中国药品研发综合实力百强榜”等荣誉。
发行价格：
11.70
{"stockData":{"symbol":"603669","market":"SH","secType":"STK","nameCN":"灵康药业","latestPrice":4.36,"timestamp":1779260400000,"preClose":4.39,"halted":0,"volume":8033400,"delay":0,"changeRate":-0.0068,"floatShares":712000000,"shares":712000000,"eps":-0.241,"marketStatus":"已收盘","change":-0.03,"latestTime":"05-20 15:00:00","open":4.36,"high":4.41,"low":4.29,"amount":34823500,"amplitude":0.0273,"askPrice":4.37,"askSize":1129,"bidPrice":4.36,"bidSize":113,"shortable":0,"etf":0,"ttmEps":-0.241,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779327000000},"marketStatusCode":5,"adr":0,"adjPreClose":4.39,"symbolType":"stock","openAndCloseTimeList":[[1779240600000,1779247800000],[1779253200000,1779260400000]],"highLimit":4.83,"lowLimit":3.95,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":712330243,"isCdr":false,"pbRate":5.52,"roa":"--","roe":"0.47%","epsLYR":-0.27,"committee":-0.815837,"marketValue":3106000000,"turnoverRate":0.0113,"status":1,"floatMarketCap":3106000000},"requestUrl":"/m/hq/s/603669/","defaultTab":"news","newsList":[{"id":"2636837053","title":"灵康药业（603669）披露“灵康转债”预计满足转股价格修正条件提示性公告，5月19日股价上涨0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636837053","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636837053?lang=zh_cn&edition=full","pubTime":"2026-05-19 18:18","pubTimestamp":1779185898,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘，灵康药业报收于4.39元，较前一交易日上涨0.69%，最新总市值为31.27亿元。近日，灵康药业集团股份有限公司发布关于“灵康转债”预计满足转股价格修正条件的提示性公告。若未来20个交易日内有5个交易日收盘价继续低于该水平，将可能触发转股价格向下修正条款。公司将在触发条件当日召开董事会审议是否修正转股价格，并及时履行信息披露义务。前次董事会已于2026年1月30日决定不向下修正转股价格。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900035271.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","603669","BK0239","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632623429","title":"每周股票复盘：灵康药业（603669）一季报主营收入同比上升72.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632623429","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632623429?lang=zh_cn&edition=full","pubTime":"2026-05-02 06:22","pubTimestamp":1777674130,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，灵康药业报收于4.48元，较上周的4.27元上涨4.92%。本周，灵康药业4月29日盘中最高价报4.63元。本周关注点来自业绩披露要点：灵康药业一季报主营收入8653.59万元，同比上升72.65%。业绩披露要点财务报告2026年一季报显示，灵康药业主营收入8653.59万元，同比上升72.65%；归母净利润295.59万元，同比上升115.87%；扣非净利润101.37万元，同比上升105.66%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631520812","title":"灵康药业（603669）2026年一季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2631520812","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631520812?lang=zh_cn&edition=full","pubTime":"2026-04-30 06:18","pubTimestamp":1777501098,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期灵康药业发布2026年一季报。截至本报告期末，公司营业总收入8653.59万元，同比上升72.65%，归母净利润295.59万元，同比上升115.87%。本报告期灵康药业盈利能力上升，毛利率同比增幅2.92%，净利率同比增幅109.19%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000019697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631582890","title":"图解灵康药业年报：第四季度单季净利润同比下降89.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631582890","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631582890?lang=zh_cn&edition=full","pubTime":"2026-04-29 01:02","pubTimestamp":1777395753,"startTime":"0","endTime":"0","summary":"证券之星消息，灵康药业2025年年报显示，当年度公司主营收入3.22亿元，同比下降15.09%；归母净利润-1.93亿元，同比下降47.78%；扣非净利润-1.7亿元，同比上升5.59%；其中2025年第四季度，公司单季度主营收入4062.32万元，同比下降72.69%；单季度归母净利润-1.59亿元，同比下降89.26%；单季度扣非净利润-1.14亿元，同比下降27.24%；负债率43.96%，投资收益-240.78万元，财务费用6273.43万元，毛利率43.71%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900002975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630022888","title":"每周股票复盘：灵康药业（603669）回购股份注销不调转股价","url":"https://stock-news.laohu8.com/highlight/detail?id=2630022888","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630022888?lang=zh_cn&edition=full","pubTime":"2026-04-26 05:26","pubTimestamp":1777152375,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，灵康药业报收于4.27元，较上周的4.43元下跌3.61%。根据《募集说明书》规定，本次注销导致总股本减少，需对“灵康转债”转股价格进行调整。关于注销已回购股份暨股份变动的公告灵康药业集团股份有限公司将于2026年4月22日注销已回购的8,915,893股股份。注销完成后，公司总股本由721,246,136股变更为712,330,243股，注册资本相应减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600002355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0239","BK0033","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629406768","title":"灵康药业（603669）披露关于延期披露2025年年度报告及2026年第一季度报告的公告，4月24日股价上涨0.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629406768","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629406768?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:19","pubTimestamp":1777040344,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，灵康药业报收于4.27元，较前一交易日上涨0.23%，最新总市值为30.42亿元。该股当日开盘4.25元，最高4.29元，最低4.19元，成交额达4524.65万元，换手率为1.5%。公告显示，公司原定于2026年4月25日披露《2025年年度报告》及《2026年第一季度报告》，因需进一步完善定期报告编制和复核工作，经向上海证券交易所申请，现将披露时间延期至2026年4月29日。公司董事会对此次调整给投资者带来的不便深表歉意。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400064898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","BK0056","603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625230936","title":"灵康药业（603669）披露关于变更持续督导保荐代表人的公告，4月7日股价上涨1.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625230936","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625230936?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:20","pubTimestamp":1775553632,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘，灵康药业报收于5.0元，较前一交易日上涨1.42%，最新总市值为36.06亿元。灵康药业集团股份有限公司近日收到中信证券出具的《关于更换保荐代表人的函》。因原持续督导保荐代表人向晓娟女士工作变动，中信证券委派方灏先生接替其职务，继续履行对公司公开发行可转换公司债券募集资金使用情况的持续督导义务。本次变更后，持续督导保荐代表人为何康先生和方灏先生。公司董事会对向晓娟女士在任期间的贡献表示感谢。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700024256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0033","BK0239","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625616442","title":"每周股票复盘：灵康药业（603669）灵康转债一季度转股金额为0元","url":"https://stock-news.laohu8.com/highlight/detail?id=2625616442","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625616442?lang=zh_cn&edition=full","pubTime":"2026-04-05 02:17","pubTimestamp":1775326629,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，灵康药业报收于4.93元，较上周的4.51元上涨9.31%。本周，灵康药业4月3日盘中最高价报5.12元。可转债转股结果暨股份变动公告灵康药业集团股份有限公司发布可转债转股结果暨股份变动公告。2026年1月1日至3月31日，“灵康转债”转股金额为0元，因转股形成的股份数量为0股。尚未转股的“灵康转债”金额为252,968,000元，占发行总量的48.1844%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0239","BK0033","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623338382","title":"每周股票复盘：灵康药业（603669）回应业绩预告问询","url":"https://stock-news.laohu8.com/highlight/detail?id=2623338382","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623338382?lang=zh_cn&edition=full","pubTime":"2026-03-29 02:57","pubTimestamp":1774724228,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，灵康药业报收于4.51元，较上周的4.34元上涨3.92%。本周，灵康药业3月27日盘中最高价报4.51元。本周关注点来自公司公告汇总：灵康药业就上交所关于业绩预告事项的问询函进行回复，披露医药流通业务模式及收入增长原因。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900000582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","603669","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622100905","title":"股市必读：新发布《中审亚太会计师事务所（特殊普通合伙）关于对灵康药业集团股份有限公司业绩预告有关事项的问询函的回复》","url":"https://stock-news.laohu8.com/highlight/detail?id=2622100905","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622100905?lang=zh_cn&edition=full","pubTime":"2026-03-26 03:00","pubTimestamp":1774465242,"startTime":"0","endTime":"0","summary":"中审亚太会计师事务所关于对灵康药业集团股份有限公司业绩预告有关事项的问询函的回复灵康药业集团股份有限公司就上海证券交易所关于其业绩预告有关事项的问询函作出回复，涉及医药流通业务、心脑血管类产品营业收入、与湖南丰恺思及湖南佰家康的业务模式、市场营销服务费等事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600003024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","BK0056","603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621055153","title":"生物医药板块午后再度拉升 灵康药业触及涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2621055153","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621055153?lang=zh_cn&edition=full","pubTime":"2026-03-24 13:17","pubTimestamp":1774329420,"startTime":"0","endTime":"0","summary":"每经AI快讯，3月24日，生物医药板块午后再度拉升，灵康药业（维权）触及涨停，迪哲医药、共同药业、苑东生物、诚意药业跟涨。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-24/doc-inhsaeyx3555839.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-24/doc-inhsaeyx3555839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0033","BK0056","BK4585","XBI","161726","BK0239","603669","BK4588","399441","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621082530","title":"股市必读：灵康药业（603669）3月23日收盘跌6.68%，主力净流出101.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621082530","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621082530?lang=zh_cn&edition=full","pubTime":"2026-03-24 04:42","pubTimestamp":1774298533,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，灵康药业报收于4.05元，下跌6.68%，换手率1.4%，成交量10.07万手，成交额4176.6万元。当日关注点来自交易信息汇总：灵康药业3月23日收盘报4.05元，跌6.68%，已连续3日下跌。来自资金流向：3月23日主力资金净流出101.48万元，占总成交额2.43%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400005171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0033","BK0239","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617663597","title":"每周股票复盘：灵康药业（603669）变更签字会计师及注销891万回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2617663597","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617663597?lang=zh_cn&edition=full","pubTime":"2026-03-08 03:08","pubTimestamp":1772910493,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，灵康药业报收于4.57元，较上周的4.66元下跌1.93%。本周，灵康药业3月2日盘中最高价报4.68元。公司公告汇总：股东会通过变更回购股份用途并注销议案，拟注销8,915,893股减少注册资本。本次变更不会对公司2025年度审计工作产生不利影响。表决结果为同意310,174,161股，占99.8275%；反对405,752股，占0.1305%；弃权129,948股，占0.0420%。注销后，公司总股本拟由721,246,136股变更为712,330,243股，注册资本相应减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800001083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0033","BK0239","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617525925","title":"灵康药业（603669）披露关于变更回购股份用途并注销暨减少注册资本的议案，3月5日股价上涨2.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617525925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617525925?lang=zh_cn&edition=full","pubTime":"2026-03-05 22:29","pubTimestamp":1772720956,"startTime":"0","endTime":"0","summary":"近日，灵康药业集团股份有限公司披露《关于回购账户部分股份注销通知债权人的公告》。公告显示，公司于2026年3月5日召开2026年第一次临时股东会，审议通过《关于变更回购股份用途并注销暨减少注册资本的议案》。公司将回购专用账户中尚未使用的8,915,893股股份由原定用于员工持股计划和股权激励变更为全部注销，减少注册资本。注销后，公司总股本拟由721,246,136股变更为712,330,243股，注册资本相应减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500039555.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0239","BK0056","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616356933","title":"灵康药业（603669）披露变更签字注册会计师公告，3月2日股价下跌3.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616356933","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616356933?lang=zh_cn&edition=full","pubTime":"2026-03-02 23:02","pubTimestamp":1772463753,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘，灵康药业报收于4.5元，较前一交易日下跌3.43%，最新总市值为32.46亿元。近日，灵康药业集团股份有限公司发布《关于变更签字注册会计师的公告》。公告显示，公司原聘任中审亚太会计师事务所吴军、于伟为2025年度签字注册会计师，因吴军工作调整，现变更为于伟、张财峰为签字注册会计师。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200040292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","BK0239","603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614857572","title":"灵康药业（603669）披露回购股份用途变更公告，2月27日股价上涨1.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614857572","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614857572?lang=zh_cn&edition=full","pubTime":"2026-02-27 23:02","pubTimestamp":1772204543,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，灵康药业报收于4.66元，较前一交易日上涨1.3%，最新总市值为33.61亿元。近日，灵康药业集团股份有限公司发布《2026年第一次临时股东会会议资料》公告，拟将已回购但尚未使用的8,915,893股股份用途由‘50%用于员工持股计划，50%用于股权激励’变更为‘用于注销并减少注册资本’。本次回购股份已于2023年1月9日完成，累计回购股份占公司总股本的1.2362%。注销后公司总股本将由721,246,136股变更为712,330,243股，注册资本相应减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700042954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","603669","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609483526","title":"每周股票复盘：灵康药业（603669）2025年净利预亏1.27亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609483526","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609483526?lang=zh_cn&edition=full","pubTime":"2026-02-08 03:10","pubTimestamp":1770491421,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，灵康药业报收于4.68元，较上周的4.56元上涨2.63%。本周，灵康药业2月6日盘中最高价报4.72元。灵康药业预计2025年归属于母公司所有者的净利润为-12700万元左右，同比减亏2.88%；扣除非经常性损益后的净利润为-14700万元左右，同比减亏18.41%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800001137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","603669","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609948815","title":"灵康药业（603669）披露2025年度业绩预亏公告，2月6日股价上涨1.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609948815","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609948815?lang=zh_cn&edition=full","pubTime":"2026-02-06 22:25","pubTimestamp":1770387923,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，灵康药业报收于4.68元，较前一交易日上涨1.3%，最新总市值为33.75亿元。该股当日开盘4.61元，最高4.72元，最低4.61元，成交额达3500.17万元，换手率为1.04%。近日，东方金诚国际信用评估有限公司发布关于灵康药业集团股份有限公司2025年度业绩预亏的关注公告。灵康药业预计2025年归属于母公司所有者的净利润为-12700万元左右，同比减亏2.88%；扣除非经常性损益后的净利润为-14700万元左右，同比减亏18.41%；营业收入预计为36500万元左右，同比下降3.89%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600041093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0056","BK0239","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608070885","title":"每周股票复盘：灵康药业（603669）拟注销近892万股并减少注册资本","url":"https://stock-news.laohu8.com/highlight/detail?id=2608070885","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608070885?lang=zh_cn&edition=full","pubTime":"2026-02-01 03:39","pubTimestamp":1769888349,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，灵康药业报收于4.56元，较上周的4.88元下跌6.56%。本周关注点公司公告汇总：灵康药业拟将已回购的8,915,893股股份全部用于注销并减少注册资本。本次注销后，公司总股本将由721,246,136股变更为712,330,243股，注册资本相应减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100001248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0033","BK0239","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605860409","title":"灵康药业（603669）披露2025年年度业绩预告，1月23日股价上涨1.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605860409","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605860409?lang=zh_cn&edition=full","pubTime":"2026-01-23 22:56","pubTimestamp":1769180172,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，灵康药业报收于4.88元，较前一交易日上涨1.24%，最新总市值为35.2亿元。该股当日开盘4.85元，最高4.91元，最低4.8元，成交额达3979.16万元，换手率为1.13%。近日，灵康药业集团股份有限公司披露2025年年度业绩预告。公告显示，公司预计2025年年度归属于母公司所有者的净利润为-12,700万元左右，同比减亏2.88%；扣除非经常性损益后的净利润为-14,700万元左右，同比减亏18.41%。营业收入预计为36,500万元左右，同比下降3.89%。该业绩预告未经注册会计师审计。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300043511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","603669","BK0056"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779316877783,"stockEarnings":[{"period":"1week","weight":-0.0268},{"period":"1month","weight":-0.0246},{"period":"3month","weight":-0.0542},{"period":"6month","weight":-0.1468},{"period":"1year","weight":-0.1138},{"period":"ytd","weight":-0.0439}],"compareEarnings":[{"period":"1week","weight":-0.0189},{"period":"1month","weight":0.0196},{"period":"3month","weight":0.0196},{"period":"6month","weight":0.0853},{"period":"1year","weight":0.2312},{"period":"ytd","weight":0.0487}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"灵康药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"25406人(较上一季度增加0.11%)","perCapita":"28037股","listingDate":"2015-05-28","address":"西藏自治区山南市乃东区国道349号(结巴乡段)20号","registeredCapital":"71233万元","survey":" 灵康药业集团股份有限公司的主营业务是化药处方药的研发、生产和销售。公司的主要产品是抗感染类产品、肠外营养类产品、消化系统类产品、心脑血管类产品、其他药品类产品、医药流通、医院销售、配送。公司先后获得“中国创新力医药企业”、“中国药品研发综合实力百强榜”等荣誉。","listedPrice":11.7},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"灵康药业(603669)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供灵康药业(603669)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"灵康药业,603669,灵康药业股票,灵康药业股票老虎,灵康药业股票老虎国际,灵康药业行情,灵康药业股票行情,灵康药业股价,灵康药业股市,灵康药业股票价格,灵康药业股票交易,灵康药业股票购买,灵康药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"灵康药业(603669)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供灵康药业(603669)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}